SPL Set ID: 4fc50afb-67f3-4bf3-9ec3-cc12734f47fd
1 drug(s) with this SPL Set ID
Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure: Divalproex sodium occurs as a white powder with a characteristic odor. Divalproex sodium delayed-release tablets, USP are for oral administration. Divalproex sodium delayed-release tablets, USP are supplied in three dosage strengths containing divalproex sodium equivalent to 125 mg, 250 mg, or 500 mg of valproic acid. Inactive Ingredients Divalproex sodium delayed-release tablets, USP contain the following inactive ingredients: methacrylic acid copolymer type C, povidone, pregelatinized corn starch, silicon dioxide, simethicone emulsion, sodium bicarbonate, sodium lauryl sulfate, talc, triethyl citrate, titanium dioxide, vanillin. The tablets are imprinted using a pharmaceutical ink. In addition, individual tablets contain: 125 mg tablets: FD&C Red No. 40. 250 mg tablets: FD&C Yellow No. 6 and iron oxide red. 500 mg tablets: FD&C Red No. 40. Chemical Structure